Open access · US-GOV via ClinicalTrials.gov Clinical trial

Autologous Platelet-Rich Plasma (PRP) Infusions and Biomarkers of Ovarian Rejuvenation and Aging Mitigation

Authors not listed

Ascendance Biomedical · 2017

Chronic inflammation Human Randomized controlled trial

Abstract

The Inovium Ovarian Rejuvenation Treatment is a PRP-based autologous treatment used in combination with a stimulated IVF sequence and Pre-Implantation Genetic Screening to treat infertility in women experiencing menopause, perimenopause, and premature ovarian failure.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-15 MST

Cite this

APA

Anonymous. (2017). Autologous Platelet-Rich Plasma (PRP) Infusions and Biomarkers of Ovarian Rejuvenation and Aging Mitigation. <em>Ascendance Biomedical</em>. https://clinicaltrials.gov/study/NCT03178695

Vancouver

Anonymous. Autologous Platelet-Rich Plasma (PRP) Infusions and Biomarkers of Ovarian Rejuvenation and Aging Mitigation. Ascendance Biomedical. 2017.

BibTeX

@misc{anon2017Autolo, title = {Autologous Platelet-Rich Plasma (PRP) Infusions and Biomarkers of Ovarian Rejuvenation and Aging Mitigation}, author = {Anonymous}, journal = {Ascendance Biomedical}, year = {2017}, }